ArticleAnnals of medicine2025
Bidirectional association of daily steps with sarcopenia: a longitudinal study.
Article in Annals of medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Letter to the editor regarding: 'bidirectional association of daily steps with sarcopenia: a longitudinal study'.Annals of medicine · 2026Article
- Letter to the Editor regarding to 'Bidirectional association of daily steps with sarcopenia: a longitudinal study'.Annals of medicine · 2026Article
- Response to letter regarding 'bidirectional association of daily steps with sarcopenia: a longitudinal study'.Annals of medicine · 2026Article
- Response to letter regarding 'Bidirectional association of daily steps with sarcopenia: a longitudinal study'.Annals of medicine · 2026Article
- Association between creatinine to cystatin C ratio and the incidence of depressive symptoms among middle-aged and older adults: insight from the CHARLS study.BMC psychology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundStep count is a well-established measure of physical activity, and step-based recommendations offering practical public guidance. However, the bidirectional associations between step count and sarcopenia remain unclear, limiting the application of step-based interventions for sarcopenia prevention. This study examined the directional association between daily steps and sarcopenia.
methodsData were collected from the Xiangya Step Study (a population-based longitudinal study) between January 2020 and December 2022. Average daily steps were tracked
resultsThe study included 1,281 participants (30.1% women), averaging 52.1 years. A significant bidirectional association was observed: fewer daily steps at baseline were associated with sarcopenia status one year later (cross-lagged path coefficient [β]=-1.20, 95%CI: -1.90 to -0.50,
conclusionsThis study highlights a bidirectional inverse association between average daily steps and sarcopenia. Increasing daily steps, especially to 5,000, might help mitigate sarcopenia development. Future research could explore interventions that increase daily steps to prevent sarcopenia and investigate whether sarcopenia reversal could improve physical activity levels.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.